The Effect of Rituximab Treatment and Reducing Immunosuppression on the Development of Post-Transplant Lymphoproliferative Disorder in EBV-Positive Patients after Solid Organ Transplantation

Orlando, E., Ford, M., Jin, Z., Lipsky, A. H., Sawas, A., Pro, B., & Amengual, J. E. (2022). The Effect of Rituximab Treatment and Reducing Immunosuppression on the Development of Post-Transplant Lymphoproliferative Disorder in EBV-Positive Patients after Solid Organ Transplantation. Blood, 140(Supplement 1), 12085–12086. https://doi.org/10.1182/blood-2022-158050
Authors:
Evelyn Orlando
Maegan Ford
Zhezhen Jin
Andrew Lipsky
Ahmed Sawas
Barbara Pro
Jennifer E. Amengual
Affiliated Authors:
Evelyn Orlando
Maegan Ford
Zhezhen Jin
Andrew Lipsky
Ahmed Sawas
Barbara Pro
Jennifer E. Amengual
Columbia Affiliation:
Subjects:
Viral-Related Cancers in Immunocompromised Patients (OpenAlex Topic)
Polyomavirus-Associated Carcinogenesis and Clinical Manifestations (OpenAlex Topic)
Epidemiology and Management of Cytomegalovirus Infection (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/blood-2022-158050
DOI:
10.1182/blood-2022-158050
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: